triumeq

Generic: abacavir sulfate, dolutegravir sodium, lamivudine

Labeler: viiv healthcare company
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name triumeq
Generic Name abacavir sulfate, dolutegravir sodium, lamivudine
Labeler viiv healthcare company
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

abacavir sulfate 600 mg/1, dolutegravir sodium 50 mg/1, lamivudine 300 mg/1

Manufacturer
ViiV Healthcare Company

Identifiers & Regulatory

Product NDC 49702-231
Product ID 49702-231_4018a8c7-db0d-481e-b50a-a469ba32ec4b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA205551
Listing Expiration 2027-12-31
Marketing Start 2014-08-22

Pharmacologic Class

Established (EPC)
hepatitis b virus nucleoside analog reverse transcriptase inhibitor [epc] human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor [epc]
Mechanism of Action
nucleoside reverse transcriptase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 49702231
Hyphenated Format 49702-231

Supplemental Identifiers

RxCUI
1546888 1546894 2598348 2598352
UPC
0349702231139
UNII
J220T4J9Q2 1Q1V9V5WYQ 2T8Q726O95
NUI
N0000175656 N0000175462 N0000009947

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name triumeq (source: ndc)
Generic Name abacavir sulfate, dolutegravir sodium, lamivudine (source: ndc)
Application Number NDA205551 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 600 mg/1
  • 50 mg/1
  • 300 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED in 1 BOTTLE (49702-231-13)
source: ndc

Packages (1)

49702-231-13 30 TABLET, FILM COATED in 1 BOTTLE (49702-231-13)

Ingredients (3)

abacavir sulfate (600 mg/1) dolutegravir sodium (50 mg/1) lamivudine (300 mg/1)

Linked Drug Pages (1)

Triumeq, Triumeq PD ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4018a8c7-db0d-481e-b50a-a469ba32ec4b", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "upc": ["0349702231139"], "unii": ["J220T4J9Q2", "1Q1V9V5WYQ", "2T8Q726O95"], "rxcui": ["1546888", "1546894", "2598348", "2598352"], "spl_set_id": ["2997739a-aa91-42aa-a206-a70e2db7b84f"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["ViiV Healthcare Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (49702-231-13)", "package_ndc": "49702-231-13", "marketing_start_date": "20140822"}], "brand_name": "Triumeq", "product_id": "49702-231_4018a8c7-db0d-481e-b50a-a469ba32ec4b", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 1A1 Inhibitors [MoA]", "HIV Integrase Inhibitors [MoA]", "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "49702-231", "generic_name": "abacavir sulfate, dolutegravir sodium, lamivudine", "labeler_name": "ViiV Healthcare Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Triumeq", "active_ingredients": [{"name": "ABACAVIR SULFATE", "strength": "600 mg/1"}, {"name": "DOLUTEGRAVIR SODIUM", "strength": "50 mg/1"}, {"name": "LAMIVUDINE", "strength": "300 mg/1"}], "application_number": "NDA205551", "marketing_category": "NDA", "marketing_start_date": "20140822", "listing_expiration_date": "20271231"}